References
- Mohyuddin GR, Rabinowitz I. A patient with chronic lymphocytic leukemia and acquired angioedema: Correlation of clinical and biochemical response to CLL therapy. Ecancer. 2013;7:292.
- Castelli R, Deliliers DL, Zingale LC, et al. Lymphoproliferative disease and acquired C1 inhibitor deficiency. Hematologica/Hematol J. 2007;92(5):716–718.
- Hall AM, Vickers MA, McLeod E, et al. Rh Autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells. Blood. 2005;105(5):2007–2015.
- Circardi M, Zanichelli M. Acquired angioedema. Asthma Clin Immunol. 2010;6:14.
- Cugno M, Castelli R, Cicardi M. Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation. Autoimmun Rev. 2008;8(2):156–159.
- Jung M, Rice L. "Surgical" abdomen in a patient with chronic lymphocytic leukemia: a case of acquired angioedema. J Gastrointest Surg. 2011;15(12):2262–2266.
- Zuraw BL, Busse PJ, White M, et al. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med. 2010;363(6):513–522.
- Bork K, Bygum A, Hardt J. Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. Ann Allergy Asthma Immunol. 2008;100(2):153–161.